Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 2200 of 2228 entries
View as:

The Study Observes How Long Patients With Non-small Cell Lung Cancer (NSCLC) Benefit From Treatment With Epidermal Growth Factor Tyrosine Kinase Inhibitor (EGFR-TKI) When Given Either for Uncommon Mutations or for Common Mutations in the Sequence Afatinib Followed by Osimertinib

Phase: N/A Priority: Normal
NCT ID: NCT04179890 Org: User:
Start: 12/17/19 End: 07/22/21 Due: 07/22/22

Study to Determine the Pharmacokinetics on TPV/r in Subjects With Mild and Moderate Hepatic Insufficiency

Phase: N/A Priority: Normal
NCT ID: NCT02249442 Org: User:
Start: 10/01/03 End: - Due: -

Clotrimazole vs. Mycelex® in Patients With Human Insufficiency Virus (HIV) Infection for the Treatment of Oropharyngeal Candidiasis

Phase: N/A Priority: Normal
NCT ID: NCT02184351 Org: User:
Start: 05/31/01 End: - Due: -

Pharmacokinetics and Pharmacodynamic Effect of Different Multiple Oral Doses of BI 425809

Phase: N/A Priority: Normal
NCT ID: NCT02362516 Org: User:
Start: 02/28/15 End: 06/30/15 Due: 06/30/16

COVID-19 Tests: Nasopharyngeal Swab vs Saliva Collected With Salivette® Cortisol for Viral RNA Sampling for RT-qPCR

Phase: N/A Priority: Normal
NCT ID: NCT04599959 Org: User:
Start: 10/26/20 End: 01/20/21 Due: 01/20/22

Spiriva® in Patients With Chronic Obstructive Pulmonary Disease (COPD) in Daily Practice

Phase: N/A Priority: Normal
NCT ID: NCT02172495 Org: User:
Start: 06/30/02 End: - Due: -

A Study of BIBR 1048 in Prevention of Venous Thromboembolism in Patients With TKR Surgery.

Phase: N/A Priority: Normal
NCT ID: NCT00246025 Org: User:
Start: 10/31/05 End: - Due: -

Drug Interaction Study With Rifampicin and Afatinib

Phase: N/A Priority: Normal
NCT ID: NCT01396265 Org: User:
Start: 07/31/11 End: - Due: -

Daily Use of JARDIANCE® Tablets in Japanese Elderly Patients With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT02367131 Org: User:
Start: 02/24/15 End: 09/27/16 Due: 09/27/17

Pharmacokinetics of BIBB 515 BS and Effect of Food After Oral Administration in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02266498 Org: User:
Start: 06/30/98 End: - Due: -

This Study is Done in Healthy Chinese and Japanese Volunteers; it Looks at How BI 690517 is Taken up in the Body and How Well it is Tolerated

Phase: N/A Priority: Normal
NCT ID: NCT03206632 Org: User:
Start: 07/17/17 End: 10/13/17 Due: 10/13/18

A Study to (1) Compare How BI 456906 is Taken up in the Body of Healthy People and People With Liver Problems and (2) Find Out How People With Overweight and Obesity, With and Without Liver Problems, Tolerate Different Doses of BI 456906

Phase: N/A Priority: Normal
NCT ID: NCT05296733 Org: User:
Start: 04/27/22 End: 12/29/23 Due: 12/29/24

Spiolto® Respimat® (Tiotropium/Olodaterol) Versus Triple Combination Therapy in Everyday Clinical Treatment Practice for Chronic Obstructive Pulmonary Disease (EVELUT®)

Phase: N/A Priority: Normal
NCT ID: NCT03954132 Org: User:
Start: 06/07/19 End: 09/30/21 Due: 09/30/22

Efficacy and Safety Study of Linagliptin (5 mg Administered Orally Once Daily) Over 24 Weeks, in Drug naïve or Previously Treated Type 2 Diabetic Patients With Insufficient Glycaemic Control

Phase: N/A Priority: Normal
NCT ID: NCT01214239 Org: User:
Start: 10/31/10 End: - Due: -

Efficacy and Safety of Empagliflozin Versus Sitagliptin in Patients With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01984606 Org: User:
Start: 01/31/15 End: 02/28/17 Due: 02/28/18

Bioavailability of Empagliflozin/Metformin Fixed Dose Combinations (FDCs) in Healthy Chinese Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02102932 Org: User:
Start: 05/31/14 End: 08/31/14 Due: 08/31/15

A Study to Find Out How Nintedanib is Taken up in the Body and How Well it is Tolerated in Children and Adolescents With Interstitial Lung Disease (ILD)

Phase: N/A Priority: Normal
NCT ID: NCT04093024 Org: User:
Start: 12/03/19 End: 05/24/22 Due: 05/24/23

Ipratropium Bromide/Salbutamol Delivered by the Respimat® Inhaler Compared to Ipratropium Bromide Respimat®, COMBIVENT® Inhalation Aerosol and Placebo in Adults With Chronic Obstructive Pulmonary Disease

Phase: N/A Priority: Normal
NCT ID: NCT02177253 Org: User:
Start: 10/31/02 End: - Due: -

Influence of Pantoprazole on the Pharmacokinetics of Fradafiban After Multiple Oral Doses of Lefradafiban in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02264119 Org: User:
Start: 04/30/98 End: - Due: -

Study to Investigate the Pharmacokinetics (PK) and Pharmacodynamics (PD) of Idarucizumab in Chinese Healthy Male and Female Volunteers Who Had Taken Dabigatran Etexilate and Whose Plasma Concentrations of Dabigatran Were at or Close to Steady State

Phase: N/A Priority: Normal
NCT ID: NCT03086356 Org: User:
Start: 05/10/17 End: 09/12/17 Due: 09/12/18

Patient Convenience Study (RE-SONANCE)

Phase: N/A Priority: Normal
NCT ID: NCT02684981 Org: User:
Start: 11/11/15 End: 06/01/17 Due: 06/01/18

Effect of BIBT 986 Followed by BIBT 986 Given as IV Infusion on Tissue Factor Triggered Coagulation in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02259881 Org: User:
Start: 12/31/02 End: - Due: -

A Study in Chinese Patients to Compare How Tenecteplase and Alteplase Given After a Stroke Improve Recovering of Physical Activity

Phase: N/A Priority: Normal
NCT ID: NCT04915729 Org: User:
Start: 06/22/21 End: 10/08/23 Due: 10/08/24

Filtered Trial for Telmisartan 40mg Non-responder

Phase: N/A Priority: Normal
NCT ID: NCT00550953 Org: User:
Start: 10/31/07 End: - Due: -

Efficacy and Safety of Free Combination of Tiotropium + Formoterol Compared to Formoterol and Tiotropium in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Phase: N/A Priority: Normal
NCT ID: NCT02238119 Org: User:
Start: 02/28/02 End: - Due: -